Decoy Therapeutics Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2014 | $-6.5M | $-6.6M | $76.1K | $1.5M |
| FY2015 | $-20.7M | $-21.0M | $265.6K | $6.6M |
| FY2016 | $-32.1M | $-32.6M | $559.4K | $6.6M |
| FY2017 | $-27.7M | $-27.8M | $113.5K | $4.2M |
| FY2018 | $4.2M | $4.2M | $0 | $31.0K |
| FY2019 | $-11.6M | $-11.6M | $0 | $751.6K |
| FY2020 | $-10.3M | $-10.3M | $2.6K | $319.4K |
| FY2021 | $-10.2M | $-10.2M | $0 | $559.0K |
| FY2022 | $-17.6M | $-17.6M | — | $796.8K |
| FY2023 | $-12.8M | $-12.8M | — | $524.8K |
| FY2024 | $-4.5M | $-4.5M | $0 | $273.7K |
| FY2025 | $-4.8M | $-5.4M | $577.0K | $219.1K |